Stelara® and Olumiant® Considered Promising by Lupus Experthttps://www.lupusresearch.org/stelara-olumiant-considered-promising-lupusexpert/?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+lrinews+%28Latest+News+from+the+Lupus+Research+Institute%29
"In Healio Rheumatology, Dr. Gregg Silverman, professor of medicine and pathology at NYU School of Medicine, provided an overview of potential lupus therapies in development. He highlighted ustekinumab (brand name Stelara®) and baricitinib (brand name Olumiant®) as two drugs that look particularly promising.".....
from "The Lupus Research Alliance Research"
